Evidence map›Paper›PMID 34608167›Full record

ArticleNature communications2021

Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection.

Marion Ferren, Valérie Favède, Didier Decimo, Mathieu Iampietro, Nicole A P Lieberman, Jean-Luc Weickert, Rodolphe Pelissier, Magalie Mazelier, Olivier Terrier, Anne Moscona and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Emerging microbes & infections · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The role of cell death in SARS-CoV-2 infection.Signal transduction and targeted therapy · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Marion FerrenCIRI, Centre International de Recherche en Infectiologie, Team Immunobiology of the Viral infections, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, LYON, France. marion.ferren@inserm.fr.ORCID http://orcid.org/0000-0003-4117-7411
Valérie FavèdeCIRI, Centre International de Recherche en Infectiologie, Team Immunobiology of the Viral infections, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, LYON, France.
Didier DecimoCIRI, Centre International de Recherche en Infectiologie, Team Immunobiology of the Viral infections, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, LYON, France.
Mathieu IampietroCIRI, Centre International de Recherche en Infectiologie, Team Immunobiology of the Viral infections, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, LYON, France.ORCID http://orcid.org/0000-0002-8946-3049
Nicole A P LiebermanDepartment of Laboratory Medicine, University of Washington Medical Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-9334-8150
Jean-Luc WeickertInstitut de Génétique et Biologie Moléculaire et Cellulaire (IGBMC), INSERM U1258, CNRS UMR 7104, Université de Strasbourg, Illkirch, France.
Rodolphe PelissierCIRI, Centre International de Recherche en Infectiologie, Team Immunobiology of the Viral infections, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, LYON, France.ORCID http://orcid.org/0000-0002-9878-029X
Magalie MazelierCIRI, Centre International de Recherche en Infectiologie, Team Immunobiology of the Viral infections, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, LYON, France.
Olivier TerrierCIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, LYON, France.ORCID http://orcid.org/0000-0001-9393-7684
Anne MosconaCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, USA.ORCID http://orcid.org/0000-0002-1796-8320
Matteo PorottoCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, USA.
Alexander L GreningerDepartment of Laboratory Medicine, University of Washington Medical Center, Seattle, WA, USA.
Nadia MessaddeqInstitut de Génétique et Biologie Moléculaire et Cellulaire (IGBMC), INSERM U1258, CNRS UMR 7104, Université de Strasbourg, Illkirch, France.
Branka HorvatCIRI, Centre International de Recherche en Infectiologie, Team Immunobiology of the Viral infections, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, LYON, France.ORCID http://orcid.org/0000-0003-0578-7765
Cyrille MathieuCIRI, Centre International de Recherche en Infectiologie, Team Immunobiology of the Viral infections, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, LYON, France. cyrille.mathieu@inserm.fr.ORCID http://orcid.org/0000-0002-6682-2029
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FRUniversity of Washington Medical Center · USColumbia University Irving Medical Center · USUniversity of Campania "Luigi Vanvitelli" · IT

Funding

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (National Agency for AIDS Research) GloPID-COVID-19 (ANRS-COV08_ SARSRhinCell)Fondation de France ANR-20-COVI-000
6 · The paper itself

Abstract

SARS-CoV-2 has caused a global pandemic of COVID-19 since its emergence in December 2019. The infection causes a severe acute respiratory syndrome and may also spread to central nervous system leading to neurological sequelae. We have developed and characterized two new organotypic cultures from hamster brainstem and lung tissues that offer a unique opportunity to study the early steps of viral infection and screening antivirals. These models are not dedicated to investigate how the virus reaches the brain. However, they allow validating the early tropism of the virus in the lungs and demonstrating that SARS-CoV-2 could infect the brainstem and the cerebellum, mainly by targeting granular neurons. Viral infection induces specific interferon and innate immune responses with patterns specific to each organ, along with cell death by apoptosis, necroptosis, and pyroptosis. Overall, our data illustrate the potential of rapid modeling of complex tissue-level interactions during infection by a newly emerged virus.

Indexed as

Models, BiologicalAdenosine MonophosphateAlanineAlveolar Epithelial CellsAnimalsAntiviral AgentsBrain StemCricetinaeImmunity, InnateInflammationLungNeuronsOrgan Culture TechniquesRegulated Cell DeathSARS-CoV-2Viral TropismAdenosine MonophosphateAlanineAntiviral Agentsremdesivir

Identifiers

PMID34608167
PMCPMC8490365
OpenAlexW3203877628

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.